AGL — Angle Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Market Cap
£10.16m
Enterprise Value
£8.56m
Revenue
£2.86m

REG - AIM - AIM Notice - 11/06/2024
11/06/2024 09:15Announcement
RCS - Angle PLC - Parsortix and assays being showcased at EACR 2024
11/06/2024 07:00Announcement
REG - Angle PLC - Publication of Circular
06/06/2024 16:45Announcement
REG - Angle PLC - Results of placing and subscription
05/06/2024 16:15Announcement
REG - Angle PLC - Preliminary Results
05/06/2024 07:00Announcement
REG - Angle PLC - Proposed Placing, Subscription and Open Offer
05/06/2024 07:00Announcement
RCS - Angle PLC - Study of ovarian cancer CTCs using Parsortix
16/05/2024 07:00Announcement
REG - Angle PLC - New commercial agreement with large pharma
03/05/2024 07:00Announcement
REG - Angle PLC - New commercial agreement with AstraZeneca
24/04/2024 07:00Announcement
REG - Angle PLC - US and EU patents for innovative CellKeep™ slide
22/04/2024 07:00Announcement
RCS - Angle PLC - Parsortix HER2 assay showcased at AACR 2024
08/04/2024 07:00Announcement
RCS - Angle PLC - Parsortix at European breast cancer conference
22/03/2024 07:00Announcement
RCS - Angle PLC - Potential utility in precision oncology
22/01/2024 07:00Announcement
REG - Angle PLC - Standard form for notification of major holdings
10/01/2024 13:00Announcement
REG - Angle PLC - Breakthrough clinical results
04/01/2024 07:00Announcement
REG - Angle PLC - Contract announcement with Eisai Inc.
02/01/2024 07:00Announcement
RCS - Angle PLC - Parsortix unlocks opportunities for drug discovery
11/12/2023 07:15Announcement
REG - Angle PLC - Broker Announcement
11/12/2023 07:15Announcement
RCS - Angle PLC - ANGLE launches Portrait+ CTC kit at SABCS
05/12/2023 07:15Announcement
RCS - Angle PLC - Launch of PD-L1 test to support cancer studies
09/11/2023 07:15Announcement